Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Eurofins Ntd Llc |
RCV000077966 | SCV000109795 | pathogenic | not provided | 2012-10-09 | criteria provided, single submitter | clinical testing | |
Athena Diagnostics | RCV000077966 | SCV001142894 | likely pathogenic | not provided | 2018-12-06 | criteria provided, single submitter | clinical testing | The variant results in a shift of the reading frame, and is therefore predicted to result in the loss of a functional protein. Not found in the total gnomAD dataset, and the data is high quality (0/204445 chr). |
Genome- |
RCV001800384 | SCV002045805 | pathogenic | Adrenoleukodystrophy | 2021-11-07 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV001800384 | SCV003312681 | pathogenic | Adrenoleukodystrophy | 2022-08-21 | criteria provided, single submitter | clinical testing | This sequence change creates a premature translational stop signal (p.Val167Leufs*20) in the ABCD1 gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in ABCD1 are known to be pathogenic (PMID: 11748843). For these reasons, this variant has been classified as Pathogenic. ClinVar contains an entry for this variant (Variation ID: 92327). This variant has not been reported in the literature in individuals affected with ABCD1-related conditions. This variant is not present in population databases (gnomAD no frequency). |